Novavax’s updated COVID vaccine shows response against ‘Eris’ variant
A vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing RightsAug 22 (Reuters) – Novavax Inc (NVAX.O) said on Tuesday its updated protein-based COVID-19 vaccine generated an immune response against emerging forms of coronavirus such as the “Eris” subvariant in small studies in animals.COVID… […]